Letrozol SUN 2,5 mg

5,34 53,40 

SKU: N/A Category:



The pharmacological action is antitumour.


Disseminated breast cancer, mainly in postmenopausal women, including resistance to treatment with anti-estrogens.


Hypersensitivity, premenopausal period, marked renal impairment (creatinine Cl < 10 ml/min), pregnancy, breastfeeding (discontinue).

Undesirable effects

Headache, dizziness, general weakness, nausea, vomiting, changes in appetite (more often decreased), constipation, peripheral oedema, flushing, myalgia, skin rashes, weight changes, hair thinning, gynaecological bleeding, oozing bloody vaginal discharge, skin rashes.

Method of use and dosage

Intravenously, 2.5 mg once daily daily, long course (5-10 years and over).
Precautions: It is desirable to test estrogen receptor status before starting treatment. The appropriateness of prescribing to patients without lymph node involvement is determined on an individual basis: the degree of malignancy, tumour size, presence of oestrogen receptors, age are taken into account. During the treatment period, it is not advisable to drive a car or perform other activities requiring increased attention and speed of reaction.

Additional information

substance active


Amount of substance, mg


formulaire de discharge


1 compressed, mg


Plaquettes thermoformed by package, pieces



Sun Pharmaceuticals Germany GmbH

volume de commande

1 blister of 10 compresses, 1 pack (3 blisters), 1 package (10 blisters), 1 packet (6 blisters)


There are no reviews yet.

Be the first to review “Letrozol SUN 2,5 mg”

Your email address will not be published. Required fields are marked *

Select options